Butterfly Network, Inc. (NYSE: BFLY) is a medical technology company that designs and commercializes handheld, whole-body ultrasound devices, most notably its Butterfly iQ platform, which connects to a smartphone and is intended to broaden point-of-care imaging access. The company entered the public markets in February 2021 through a business combination with GX Acquisition Corp. II, a blank-check company whose sponsor was GX Sponsor II LLC. Since completing the de-SPAC transaction, BFLY has traded on the New York Stock Exchange and continues to operate in the digital health and medical imaging sector. The company filed a Form 10-Q with the SEC on April 30, 2026, reflecting its ongoing status as a reporting public company. Visit SpacDesk and create a free account to access the full filing history, deal terms, and institutional data for BFLY.